Citigroup
BSTG

Citigroup’s Biostage, Inc. Common Stock BSTG Stock Holding History

Citigroup’s Portfolio BSTG Stock Details BSTG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-6,000
Closed -$2K – 7794
2017
Q3 		$2K Buy
+6,000
New +$2.4K ﹤0.01% 7081
2016
Q1 		– Sell
-99
Closed – – 8015
2015
Q4 		$0 Sell
99
-1,469
-94% -$2.05K ﹤0.01% 8094
2015
Q3 		$1K Buy
+1,568
New +$1.78K ﹤0.01% 7289
2015
Q1 		– Sell
-263
Closed -$1K – 7614
2014
Q4 		$1K Buy
263
+209
+387% +$1.03K ﹤0.01% 7036
2014
Q3 		$0 Sell
54
-153
-74% -$1.25K ﹤0.01% 7467
2014
Q2 		$3K Sell
207
-825
-80% -$7.03K ﹤0.01% 6682
2014
Q1 		$9K Sell
1,032
-2,632
-72% -$15.6K ﹤0.01% 6403
2013
Q4 		$18K Buy
+3,664
New +$17.1K ﹤0.01% 6217

Citigroup's BSTG Position: Q4 2017 in Review

Citigroup sold out of Biostage, Inc. Common Stock (BSTG) in Q4 2017, closing a stake of 6,000 shares — an estimated $2K sold.

Citigroup first reported a position in BSTG in Q4 2013 and held it in 8 quarters. The position peaked at $18K in Q4 2013. 0 funds tracked by Wall St. Rank hold BSTG as of Q4 2017.

  • Citigroup reported no remaining Biostage, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Citigroup sold 6,000 Biostage, Inc. Common Stock shares in Q4 2017, an estimated $2K.
  • Citigroup first reported a position in Biostage, Inc. Common Stock in Q4 2013 and held it in 8 quarters.
  • Citigroup's Biostage, Inc. Common Stock position peaked at $18K in Q4 2013.
  • 0 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q4 2017.

Based on Citigroup's 13F filing for Q4 2017, filed 12 Feb 2018.